Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELDICS: Early vs Late SLED in Cirrhotic Septic Shock
NCT02937961Unknown
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Dec 2017
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Transplant free survival at 28 days. Status: unknown.
Beyond the preview
Go deeper on NCT02937961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02937961.